Skip to content
healthcare.dev

MYHIBBIN

NDC 24338-018, MYCOPHENOLATE MOFETIL, suspension, from Azurity Pharmaceuticals, Inc..

Product NDC
24338-018
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216482
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24338-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MYCOPHENOLATE MOFETIL200 mg/mL

Pharmacologic classes

Antimetabolite Immunosuppressant [EPC]

Package NDCNDC-11Package
24338-018-01243380018011 BOTTLE, PLASTIC in 1 CARTON (24338-018-01) / 175 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d9af72d6-7b3e-4c08-94b9-1d8b499cb7f9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=24338-018

Use it

Look up 24338-018 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24338-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24338-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.